By Tony Fong

NEW YORK (GenomeWeb News) – Established diagnostics firms such as Roche and Abbott can have the batch processing market, as far as Biocartis is concerned. The Swiss-based start-up has its eyes on the decentralized molecular diagnostics space.

In February, Biocartis acquired Royal Philips Electronics' molecular diagnostic platform, and is now in the process of building it out in expectations of a late-2012 launch.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.